|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / txFQoYcINk |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Douglass Гость |
Добавлено: 02-07-2022 04:51 |
|
I've been made redundant salbutamol odchudzanie Moncef Slaoui, GSK's R&D chief, said that "we want to help create the medicines of the future and be the catalyst for this work". He added that the company "can play the integrating role that is needed to drive this new type of medical treatment all the way from the bench to the patient and this fund is a key part of our efforts". |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / txFQoYcINk |